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Migration and allergic diseases in a
rural area of a developing country
To the Editor:
Studies in developing countries (DCs) have frequently
reported a lower prevalence of allergic diseases (ADs) in rural
areas compared with urban settings, and this has been attributed
to the protective effects of environmental exposures such as
rural lifestyle.1 Recent evidence from studies conducted in Af-
rica and Asia showed that ADs are increasing in urban and even
in rural settings, reducing the urban-rural prevalence gap.2,3 It
has been hypothesized that temporal increases in the prevalence
of ADs might be associated with urbanization processes, espe-
cially with the change from rural to more modern urban
lifestyles.1
Migration is an important component of the urbanization
process and involves socioeconomic, environmental, and life-
style changes in rural and urban populations. However, the
effects of migration on ADs in urban and rural settings of DCs
have not been explored.4 The impact of migration on ADs has
been largely investigated by comparing populations that have
migrated from DCs (presumed low risk for ADs) to developed
countries (presumed high risk).5 These studies have shown
that being born in a country of low risk provides protection
against asthma, but this protection may decline with the length
of residence in the new environment.5 Others studies have
shown that age of migration and time since migration are asso-
ciated with the risk of asthma and other ADs, often leading to a
higher risk of atopy and allergy among migrants than among the
local population.6
The Social Changes, Asthma and Allergy in Latin America
(SCAALA) study has been investigating the effects of
migration on the prevalence of ADs in schoolchildren living
in rural and urban areas.4 We studied 4295 rural and 2510 ur-
ban children aged 5 to 16 years attending a convenience sam-
ple of schools in Esmeraldas province, Ecuador. Data on
potential risk factors, migration (direction and distance of
migration, age at migration, and time since migration), and
wheeze, rhinitis, and eczema symptoms within the previous
12 months were collected using an investigator-administered
questionnaire that included the core allergy questions of the
International Study of Asthma and Allergies in Childhood
(ISAAC phase II).4 Atopy was measured by skin prick testing
to 7 aeroallergens.
Results from the rural area showed that children who migrated
during the first year of life had a greater risk of wheeze and rhinitis
than did nonmigrant children and that children with a history of
international migration (children from rural areas of Colombia)
had a higher prevalence of rhinitis than did nonmigrant children
(Table I). The study also evaluated the effects of maternal
migration on allergic outcomes in children using the variables
maternal history of migration and children living with one or no
parent. These analyses suggested that children whose mothers
had a history of migration had a greater risk of eczema compared
with children whose mother did not, and children who did not live
with any parent had more wheeze than did children living with
both parents (Table I). The magnitude of the latter association
was greater for all allergic symptoms among children of migrant
mothers (Table II). No associations were observed for atopy (at
least 1 positive allergen skin test result).
The present study is unique in investigating migrants within a
rural area of a DC, where migrants come from urban and rural
settings. In this setting, age at migration and international
migration were important factors associated with a higher risk
of ADs in rural populations. A novel observation was the effect
of migrant status of the mother on the prevalence of ADs:
children of migrant mothers not living with either parent had a
2-fold greater risk of all 3 ADs compared with children living
with both parents. These data raise a question: Could it be that
social effects of migration, such as absence of parents at home,
are important determinants of the increase in ADs in rural pop-
ulations of DCs? To answer this question, we need to consider
some demographic patterns in these regions. It is well known
that people in rural villages move to urban areas, temporally
or permanently, in search of work to improve their quality of
life. A high proportion of these rural migrants are single women
who provide economic support for their families. Most of these
women leave their children in the community of origin to be
cared for by relatives. Some of these immigrants are able to
settle in the city while others return to their rural communities.7
In the SCAALA rural population, 31% of the children and 23%
of the mothers had a history of migration and 15% of the chil-
dren lived with no parent.
If the absence of parents at home (especially the mother) is an
important determinant of the increase in ADs in DCs, then 2
migration trends that have occurred over recent decades might
help us understand temporal trends in ADs. In the past, most
economic migrants were young men, but now ‘‘feminization of
migration’’ is a growing trend worldwide because of a greater
demand for female labor.8 Second, ‘‘circular migration’’ is a com-
mon phenomenon in regions that are undergoing high levels of ur-
banization, and it refers to repeated migrations between rural and
urban areas due to improvements in transport and modern forms
of communication.9
Migration affects not only the individuals who migrate but
also their family. Migration impacts on roles, support structures,
and responsibilities of family members, resulting in changes in
social and psychological factors. In the case of maternal
migration, children who remain in their community may
experience heightened levels of stress and depression because
of separation from their primary carer. Psychological mecha-
nisms have been proposed to explain how emotional factors, in
the context of family, might affect the development of allergic
diseases.10 For this reason, we propose that the absence of the
parents at home, through temporary or permanent migration,
may contribute to the increase in ADs in rural and urban popu-
lations of DCs.
Finally, further analyses in different populations living in rural
and urban areas evaluating the effects of migration on ADs are
required. A better understanding of the social, psychological, and
environmental effects of migration on ADs in DCs is required.
 2016 The Authors. Published by Elsevier Inc. on behalf of the American Academy of
Allergy,Asthma& Immunology. This is an open access article under theCCBY license
(http://creativecommons.org/licenses/by-nc/4.0/).
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TABLE I. ORs and 95% CIs for associations between migration variables and allergic symptoms adjusted for sex, age, and
socioeconomic status
Variable Category N
OR (95% CI)
Wheeze Rhinitis Eczema
Direction of migration NM 2964 1 1 1
Rural to rural 555 1.13 (0.84-1.52) 1.02 (0.7-1.49) 1.23 (0.82-1.83)
Urban to rural 776 0.97 (0.74-1.27) 1.18 (0.86-1.61) 1.16 (0.81-1.66)
Distance of migration NM 2964 1 1 1
National 1263 0.99 (0.79-1.25) 1.04 (0.79-1.38) 1.21 (0.90-1.64)
International 68 1.71 (0.88-3.32) 2.39 (1.16-4.92)* 0.64 (0.16-2.66)
Age at migration (y) NM 2964 1 1 1
<1 269 1.47 (1.02-2.12)* 1.59 (1.03-2.46)* 1.25 (0.73-2.14)
1-5 560 0.96 (0.71-1.31) 1.18 (0.83-1.69) 1.17 (0.78-1.75)
>5 502 0.88 (0.62-1.24) 0.76 (0.48-1.19) 1.16 (0.75-1.79)
Time since migration (y) NM 2964 1 1 1
<3 vs NM 383 0.98 (0.68-1.4) 0.94 (0.6-1.49) 0.96 (0.57-1.61)
3-5 vs NM 197 0.56 (0.31-1.02) 0.9 (0.48-1.69) 1.53 (0.86-2.7)
>5 vs NM 751 1.21 (0.94-1.58) 1.26 (0.92-1.73) 1.21 (0.85-1.73)
Maternal history of migration No 3314 1 1 1
Yes 981 1.22 (0.96-1.53) 1.24 (0.93-1.65) 1.88 (1.39-2.53)*
Parents living in the child’s house Both 2490 1 1 1
One 1146 1.07 (0.84-1.36) 1.16 (0.87-1.54) 1.21 (0.88-1.67)
None 659 1.57 (1.2-2.05)* 1.29 (0.92-1.81) 1.27 (0.86-1.86)
NM, No migrant; OR, odds ratio.
Outcomes were defined as recent wheeze—reported wheezing during the previous 12 months; recent eczema—having a reported itchy rash with a flexural distribution in the
previous 12 months; and recent rhinitis—nasal stuffiness or sneezing without a cold accompanied by itchy eyes in the previous 12 months.
*P < .05.
TABLE II. ORs and 95% CIs for associations between allergic symptoms and parents living in the child’s home (live with parents)
stratified by maternal history of migration*
Allergic symptom Live with parents
Maternal history of migration
No Yes
OR* 95% CI P value OR* 95% CI P value
Wheeze One vs both 1 0.76-1.34 .976 1.2 0.77-1.87 .429
None vs both 1.44 1.06-1.95 .02 2.17 1.25-3.77 .006
Rhinitis One vs both 1.03 0.73-1.46 .858 1.46 0.85-2.52 .171
None vs both 1.1 0.74-1.64 .627 2.07 1.05-4.08 .036
Eczema One vs both 0.96 0.63-1.46 .857 1.63 0.95-2.77 .074
None vs both 1.03 0.64-1.65 .916 2.12 1.07-4.17 .031
OR, Odds ratio.
*ORs adjusted for sex, age, and socioeconomic status.
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Persistent nodal histoplasmosis in
nuclear factor kappa B essential
modulator deficiency: Report of a
case and review of infection in pri-
mary immunodeficiencies
To the Editor:
Histoplasma capsulatum var. capsulatum is an endemic
dimorphic intracellular fungus that typically causes asymptom-
atic and self-limited infections in immunocompetent individuals.1
Inversely, immunocompromised patients, particularly patients
with the acquired immunodeficiency syndrome and other cell-
mediated immune defects, are at increased risk for disseminated
histoplasmosis.1
Here, we report the first case of persistent nodal histoplasmosis
in a patient deficient in nuclear factor kappa B (NF-kB) essential
modulator (NEMO). NEMO is required for activation ofNF-kB, a
key transcription factor for both innate and adaptive immunity.
Multiple cell surface receptors converge on the induction of
NF-kB activation, including CD40, the Toll-like receptors,
TNF-a receptor, IL-1 receptor, and the receptor for ectoderm
formation, ectodysplasin.2
Amorphic mutations in the X-linked gene for NEMO (IKBKG)
are lethal prenatally in males, but cause incontinentia pigmenti in
females.3 Lyonization allows cells with normal NEMO
expression to survive; however, those cells with completely
absent expression die with inflammatory consequences.3
Hypomorphic NEMO mutations resulting in reduced activation
of NF-kB permit male survival and cause a spectrum of
conditions, including ectodermal dysplasia, invasive pneumo-
coccal diseases, and mycobacterial disease.3,4
Reduced natural killer cell function, variable hypogamma-
globulinemia, and impaired function of the receptors of
innate immunity predispose to viral, pyogenic bacterial, and
mycobacterial infections.5 NEMO mutations can also impair
CD40 signaling in monocytes, leading to diminished IL-12
secretion and therefore impaired IFN-g production and
increased susceptibility to mycobacterial infections, suggesting
that activation of NF-kB by NEMO is essential for the destruction
of intracellular pathogens.4
A 52-year-old man with NEMO deficiency presented to our
institution with 1 year of mildly worsening dyspnea and intermit-
tent night sweats.Amutation had been identifiedpreviously in exon
1b of IKBKG (c.1-16C>G), resulting in abnormally spliced tran-
scripts.6 He had a history of Haemophilus influenzae pericarditis
in childhood and disseminated Mycobacterium avium predomi-
nantly involving the thigh and perineum in his 30s, which was
treated successfully with antimycobacterials and IFN-g. His
nontuberculous mycobacterial infection had been well controlled
for over 10 years on ethambutol, azithromycin, and moxifloxacin,
but IFN-g had been stopped.
Computed tomography (CT) of the chest showed a new right
superior perihilar mass (2.2 cm3 1.6 cm) with necrosis and areas
of peribronchial thickening (Fig 1, A). Repeat chest CT 3 months
later showed interval increase (2.5 cm 3 1.8 cm) of the perihilar
mass with development of tree-in-bud opacities and larger
mediastinal lymph nodes.
Histopathology of a paratrachal lymph node biopsy showed
chronic inflammatory changes with granulomatous inflammation
and rare small yeast forms (Fig 1, B). Fungal culture from the
lymph node biopsy grew H capsulatum. Urine was also positive
for Histoplasma antigen. Bronchoalveolar lavage, blood, and
urine fungal cultures were all negative. Posaconazole 300 mg
daily was initiated. At 3 months, he was clinically improved
and CT showed improvement in lung opacities and right hilar
lymphadenopathy.
A search of the National Institutes of Health patient databases
for unpublished cases of histoplasmosis in patients with
known primary immunodeficiencies (PIDs) was conducted.
All patients had provided informed consent on approved
protocols of the National Institute of Allergy and Infectious
Diseases at the National Institutes of Health. We identified 4
unpublished cases of histoplasmosis: disseminated histoplasmo-
sis in GATA2 deficiency (patient 1), CD40L deficiency (patient
2), and idiopathic CD4 lymphocytopenia (ICL; patient 4) and
lymphadenitis in CD40L deficiency (patient 3). Patients’ clinical
descriptions are provided in this article’s Online Repository at
www.jacionline.org and are summarized in Tables E1 and E3 in
this article’s Online Repository at www.jacionline.org.
A systematic search of all published cases of histoplasmosis in
patients with PID was conducted through August 2015. In
PubMed, PubMed Central, Scopus, Embase, andWeb of Science,
search termswere histoplasma, histoplasmosis, disseminated, and
immunodeficiency. All publications involving secondary or
acquired immune deficiencies were excluded. For specific PIDs
that can be defined clinically or molecularly, the following
descriptive terms were used: X-linked hyper-IgM 5 CD40L
deficiency; hyper-IgM syndrome 5 clinical phenotype; STAT3
deficiency 5 autosomal-dominant hyper-IgE; hyper-IgE
syndrome 5 clinical phenotype.
We identified 47 patients with histoplasmosis and a PID defined
molecularly or clinically. All references are summarized in
Tables E1 and E3. We classified infections as disseminated on
the basis of original classification in the publication, the presence
of H capsulatum in 2 or more tissues, or the suspected involve-
ment of multiple tissues and a positive urine or serum Histo-
plasma antigen (see Table E1).
Disseminated histoplasmosis was classified in 32 of 47 patients
(68%) with PID identified in our review. Two deaths occurred
because of progression of disseminated histoplasmosis. All 8
documented recurrences of histoplasmosis occurred in the context
of disseminated infection. Disseminated histoplasmosis had
variable clinical manifestations, most commonly with systemic
symptoms (82%), pulmonary symptoms (74%), splenomegaly
(56%), and lymphadenopathy (56%) (see Table E2 in this article’s
Online Repository at www.jacionline.org). Notably, out of 10
cases of histoplasmosis in molecularly or clinically diagnosed
autosomal-dominant hyper-IgE syndrome (STAT3 deficiency), 8
patients presented with gastrointestinal complaints, including 3
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